EE04580B1 - Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum - Google Patents

Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum

Info

Publication number
EE04580B1
EE04580B1 EEP200100356A EEP200100356A EE04580B1 EE 04580 B1 EE04580 B1 EE 04580B1 EE P200100356 A EEP200100356 A EE P200100356A EE P200100356 A EEP200100356 A EE P200100356A EE 04580 B1 EE04580 B1 EE 04580B1
Authority
EE
Estonia
Prior art keywords
strain
micro
probiotic
organism
oxidative
Prior art date
Application number
EEP200100356A
Other languages
English (en)
Inventor
Mikelsaar Marika
Zilmer Mihkel
Kullisaar Tiiu
Annuk Heidi
Songisepp Epp
Original Assignee
Tartu �likool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tartu �likool filed Critical Tartu �likool
Priority to EEP200100356A priority Critical patent/EE04580B1/et
Priority to ES02742853T priority patent/ES2356119T3/es
Priority to EP02742853A priority patent/EP1401457B1/en
Priority to RU2003137810/13A priority patent/RU2284354C2/ru
Priority to US10/481,713 priority patent/US7244424B2/en
Priority to DE60238482T priority patent/DE60238482D1/de
Priority to DK02742853.1T priority patent/DK1401457T3/da
Priority to PCT/EE2002/000006 priority patent/WO2003002131A1/en
Priority to AT02742853T priority patent/ATE489959T1/de
Publication of EE200100356A publication Critical patent/EE200100356A/et
Publication of EE04580B1 publication Critical patent/EE04580B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
EEP200100356A 2001-06-29 2001-06-29 Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum EE04580B1 (et)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EEP200100356A EE04580B1 (et) 2001-06-29 2001-06-29 Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
ES02742853T ES2356119T3 (es) 2001-06-29 2002-06-21 Cepa del microorganismo lactobacillus fermentum me-3 como nuevo probiótico antioxidante.
EP02742853A EP1401457B1 (en) 2001-06-29 2002-06-21 Strain of micro-organism lactobacillus fermentum me-3 as novel antioxidative probiotic
RU2003137810/13A RU2284354C2 (ru) 2001-06-29 2002-06-21 Пробиотик
US10/481,713 US7244424B2 (en) 2001-06-29 2002-06-21 Strain of micro-organism Lactobacillus fermentum ME-3 as novel anti-microbiol and anti-oxidative probiotic
DE60238482T DE60238482D1 (de) 2001-06-29 2002-06-21 Mikroorganismus stamm lactobacillus fermentum me-3 als neues antioxidatives probiotisches mittel
DK02742853.1T DK1401457T3 (da) 2001-06-29 2002-06-21 Stamme af mikroorganismen lactobacillus fermentum ME-3 som nyt antioxidativt probiotika
PCT/EE2002/000006 WO2003002131A1 (en) 2001-06-29 2002-06-21 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic
AT02742853T ATE489959T1 (de) 2001-06-29 2002-06-21 Mikroorganismus stamm lactobacillus fermentum me- 3 als neues antioxidatives probiotisches mittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EEP200100356A EE04580B1 (et) 2001-06-29 2001-06-29 Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum

Publications (2)

Publication Number Publication Date
EE200100356A EE200100356A (et) 2003-02-17
EE04580B1 true EE04580B1 (et) 2006-02-15

Family

ID=8161768

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100356A EE04580B1 (et) 2001-06-29 2001-06-29 Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum

Country Status (9)

Country Link
US (1) US7244424B2 (et)
EP (1) EP1401457B1 (et)
AT (1) ATE489959T1 (et)
DE (1) DE60238482D1 (et)
DK (1) DK1401457T3 (et)
EE (1) EE04580B1 (et)
ES (1) ES2356119T3 (et)
RU (1) RU2284354C2 (et)
WO (1) WO2003002131A1 (et)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040170617A1 (en) * 2000-06-05 2004-09-02 Finegold Sydney M. Method of treating diseases associated with abnormal gastrointestinal flora
AU2003224355A1 (en) * 2003-04-02 2004-10-25 Axcel Photonics, Inc. Lactobacillus fermentum strain and uses thereof
DE102005062731A1 (de) * 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
TWI346554B (en) 2008-04-30 2011-08-11 Genmont Biotech Inc Lactobacillus isolates having anti-inflammatory activities and uses of the same
UA106381C2 (ru) * 2009-06-30 2014-08-26 Кр. Хансен А/С Способ получения ферментированного молочного продукта
WO2011083353A1 (en) 2010-01-08 2011-07-14 Compagnie Gervais Danone Method for selecting bacteria with anti-oxidant action
EA024911B1 (ru) 2010-01-08 2016-11-30 Компани Жервэ Данон Лактобациллы с антиоксидантным действием
US9707207B2 (en) 2010-05-26 2017-07-18 The United States Of America As Represented By The Department Of Veterans Affairs Method for diagnosing, preventing, and treating neurological diseases
RU2453591C1 (ru) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus rhamnosus, используемый для получения продукции, содержащей лактобактерии
US20140147427A1 (en) * 2011-06-08 2014-05-29 Organobalance Gmbh Spray-Dried Lactobacillus Stems/Cells and the Use of Same Against Helicobacter Pylori
EP2782581A4 (en) * 2011-10-27 2015-05-20 Salix Pharmaceuticals Inc ELEKTROLYT laxatives
JP6084162B2 (ja) * 2011-10-28 2017-02-22 株式会社明治 ナチュラルチーズおよびその製造方法
GB201223370D0 (en) * 2012-12-24 2013-02-06 Univ Tartu Method of treatment using lactobacillus fermentum ME-3
US20160279180A1 (en) * 2013-08-23 2016-09-29 Consejo Superior de Investigaciones Científicas ( CSIC) Probiotic Strain of Lactobacillus Reuteri Exhibiting Anti-Helicobacter Activity, a Probiotic or Biotherapeutic Product Comprising Said Strain, and the Use Thereof
RS57471B1 (sr) * 2015-12-17 2018-09-28 Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu Nova probiotička starter kultura za humanu i animalnu primenu
CN106967630B (zh) * 2016-12-01 2019-12-10 广东省微生物研究所（广东省微生物分析检测中心） 一种发酵乳杆菌及其应用
RU2705250C2 (ru) * 2018-02-05 2019-11-06 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Штамм Lactobacillus fermentum U-21, продуцирующий комплекс биологически активных веществ, осуществляющих нейтрализацию супероксид-аниона, индуцируемого химическими агентами
RU2757118C2 (ru) * 2019-12-11 2021-10-11 Общество с ограниченной ответственностью "Фармабиотики" Применение клеток штамма Lactobacillus fermentum U-21 для предотвращения патологических изменений в тканях, вызванных оксидативным стрессом
KR102424594B1 (ko) * 2020-11-30 2022-07-25 파이토지노믹스 주식회사 항염 활성 및 유해 미생물에 대한 항균 활성을 가지는 락토바실러스 퍼멘텀 okbl-l.fe 1 균주 및 이의 용도
CN116574630B (zh) * 2023-01-31 2024-02-20 江苏省农业科学院 具有抑菌和抗氧化活性的乳杆菌、适用于秸秆青贮的复合微生物菌剂及其应用
CN116590175A (zh) * 2023-04-12 2023-08-15 吉林省中科特殊食品创新研究院有限公司 一种发酵乳杆菌elf041及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
KR100211529B1 (ko) 1997-04-28 1999-08-02 박원훈 유해 미생물 억제 활성을 갖는 신규 내산성 락토바실러스 속 미생물 및 이를 함유하는 가축용 생균활성제
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
RU2133272C1 (ru) 1998-06-11 1999-07-20 Акционерное общество открытого типа "Биомед" им.И.И.Мечникова Штамм бактерии lactobacillus fermentum 90-ts-4(21), используемый для получения эубиотического препарата для применения в гинекологической практике
AU1543400A (en) * 1998-12-11 2000-07-03 Urex Biotech Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection

Also Published As

Publication number Publication date
DK1401457T3 (da) 2011-01-17
WO2003002131A1 (en) 2003-01-09
RU2003137810A (ru) 2005-05-20
EE200100356A (et) 2003-02-17
ATE489959T1 (de) 2010-12-15
US20040151708A1 (en) 2004-08-05
ES2356119T3 (es) 2011-04-05
WO2003002131B1 (en) 2003-03-06
US7244424B2 (en) 2007-07-17
DE60238482D1 (de) 2011-01-13
EP1401457A1 (en) 2004-03-31
EP1401457B1 (en) 2010-12-01
RU2284354C2 (ru) 2006-09-27

Similar Documents

Publication Publication Date Title
EE04580B1 (et) Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
Aguilar-Galvez et al. Potential of tara (Caesalpinia spinosa) gallotannins and hydrolysates as natural antibacterial compounds
Abuelsaad et al. Antimicrobial and immunomodulating activities of hesperidin and ellagic acid against diarrheic Aeromonas hydrophila in a murine model
Piekarska-Radzik et al. Mutual influence of polyphenols and Lactobacillus spp. bacteria in food: A review
Gotteland et al. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?
Poppi et al. Effect of Lactobacillus sp. isolates supernatant on Escherichia coli O157: H7 enhances the role of organic acids production as a factor for pathogen control
Sunanliganon et al. Lactobacillus plantarum B7 inhibits Helicobacter pylori growth and attenuates gastric inflammation
Kumar et al. The ameliorative effects of probiotic Lactobacillus fermentum strain RS-2 on alloxan induced diabetic rats
Lim Purification and characterization of two bacteriocins from Lactobacillus brevis BK11 and Enterococcus faecalis BK61 showing anti-Helicobacter pylori activity
Viedma et al. Enhanced bactericidal effect of enterocin AS-48 in combination with high-intensity pulsed-electric field treatment against Salmonella enterica in apple juice
OSAWA et al. The antibacterial activities of peppermint oil and green tea polyphenols, alone and in combination, against Enterohemorrhagic Escherichia coil
Jiang et al. Effect of an essential oils blend on growth performance, and selected parameters of oxidative stress and antioxidant defence of Escherichia coli challenged piglets.
Lee et al. Antioxidant and antibacterial activities of Lactobacillus-fermented Artemisia annua L. as a potential fish feed additive
Manyi-Loh et al. Treatment of Helicobacter pylori infections: mitigating factors and prospective natural remedies
Aditya et al. Antagonistic effects of phenolic extracts of Chokeberry pomace on E. coli O157: H7 but not on probiotic and normal bacterial flora
Kim et al. Antibacterial activity of crude Aronia melanocarpa (black chokeberry) extracts against Bacillus cereus, Staphylococcus aureus, Cronobacter sakazakii, and Salmonella Enteritidis in various dairy foods: Preliminary study
Kaur et al. Dietary antioxidants and infectious diseases
François et al. Antimicrobial activity of probiotic strain Lactobacillus plantarum isolated from" sha'a" and assessment of its viability in local honey.
KR102065180B1 (ko) 클로스트리디오이데스 디피실레에 항균 활성을 갖는 락토바실러스 속 WiKim0092 균주 및 이를 포함하는 조성물
KR102065181B1 (ko) 클로스트리디오이데스 디피실레에 항균 활성을 갖는 락토바실러스 속 WiKim0093 균주 및 이를 포함하는 조성물
Elamary et al. Efficiency of certain vegetables under various storage conditions against the meat-borne Escherichia coli isolates
WO2019209086A1 (ko) 류코노스톡 메젠테로이드 균주 및 이의 용도
Hu JuWu et al. Antibacterial and antioxidant effects of three chlorogenic acid extracts.
Haghighatafshar et al. The effect of bacteriocin isolated from Lactobacillus rhamnosus on Pseudomonas aeruginosa lipopolysaccharides
Rukayadi et al. Antibacterial and sporicidal activity of macelignan isolated from nutmeg (Myristica fragrans Houtt.) against Bacillus cereus

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231